CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to advance antiviral drug development by training researchers in multidisciplinary approaches. It brings together academic and industrial partners to provide comprehensive training and foster collaboration between academia and industry in the field of antiviral therapies.
Viral infections are a major cause of disease, mortality and economic losses worldwide.
Antiviral therapy is an essential instrument to control virus infections.
At present, however, licensed antiviral drugs have been developed only against a limited number of viruses (e.g. HIV, HCV, influenza, herpesviruses).
There is a clear and unmet need for antiviral drugs to treat infections with other important human pathogens.Europe needs well-trained experts with multidisciplinary skills to advance the…
UNIVERSITEIT UTRECHT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Leiden University Medical Center
Netherlands, Leiden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Heidelberg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Cardiff
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Marseille
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
